English   español  
Please use this identifier to cite or link to this item: http://hdl.handle.net/10261/198929
logo share SHARE   Add this article to your Mendeley library MendeleyBASE

Visualizar otros formatos: MARC | Dublin Core | RDF | ORE | MODS | METS | DIDL | DATACITE
Exportar a otros formatos:


The influence of lung microbiota on lung carcinogenesis, immunity, and immunotherapy

AuthorsRamírez-Labrada, Ariel; Isla, Dolores; Artal, A.; Arias, Maykel; Rezusta, Antonio; Pardo, Julián; Gálvez Buerba, Eva Mª CSIC ORCID
KeywordsLung microbiota
Lung carcinogenesis
Issue Date18-Jan-2020
CitationTrends in Cancer 6(2): 86-97 (2020)
AbstractMicrobiota have emerged as key modulators of both the carcinogenic process and the immune response against cancer cells, and, thus, it seems to influence the efficacy of immunotherapy. While most studies have focused on analyzing the influence of gut microbiota, its composition substantially differs from that in the lung. Here, we describe how microbial life in the lungs is associated with host immune status in the lungs and, thus, how the identification of the microbial populations in the lower respiratory tract rather than in the gut might be key to understanding the lung carcinogenic process and to predict the efficacy of different treatments. Understanding the influence of lung microbiota on host immunity may identify new therapeutic targets and help to design new immunotherapy approaches to treat lung cancer.
Description2 Figuras, 1 Tabla
Publisher version (URL)http://dx.doi.org/10.1016/j.trecan.2019.12.007
Appears in Collections:(ICB) Artículos
Files in This Item:
File Description SizeFormat 
Trends in Cancer 6_2_86-97_2020.pdf1,68 MBAdobe PDFThumbnail
Show full item record
Review this work

WARNING: Items in Digital.CSIC are protected by copyright, with all rights reserved, unless otherwise indicated.